Form 8-K - Current report:
SEC Accession No. 0001437749-25-008671
Filing Date
2025-03-21
Accepted
2025-03-21 09:05:01
Documents
14
Period of Report
2025-03-21
Items
Item 1.03: Bankruptcy or Receivership
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Document Format Files

Seq Description Document Type Size
1 FORM 8-K krbp20250321_8k.htm   iXBRL 8-K 24431
  Complete submission text file 0001437749-25-008671.txt   166290

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA krbp-20250321.xsd EX-101.SCH 3579
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE krbp-20250321_def.xml EX-101.DEF 11816
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE krbp-20250321_lab.xml EX-101.LAB 15874
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krbp-20250321_pre.xml EX-101.PRE 12031
16 EXTRACTED XBRL INSTANCE DOCUMENT krbp20250321_8k_htm.xml XML 2951
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Filer) CIK: 0001792581 (see all company filings)

EIN.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39619 | Film No.: 25758693
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)